Global RWE leader brings more than 20 years of pharmaceutical, CRO, and regulatory expertise to strengthen UBC’s evidence generation capabilities.
King of Prussia, PA – 27 January 2026 | United BioSource LLC (UBC) today announced the appointment of Massoud Toussi, MD, PhD, as Vice President, Real World Evidence. Dr. Toussi will lead the global strategy and execution of UBC’s Real World Evidence capabilities, bolstering the company’s scientific offerings and supporting both commercial and R&D partners.
Dr. Toussi is a physician–scientist and gllobal expert in Real World Evidence (RWE), Real World Data (RWD), and pharmacoepidemiology, with more than 20 years of experience across the pharmaceutical industry, CROs, regulatory agencies, and nonprofit sectors. Most recently, he served as Vice President and Global Head of RWE at Cytel. He has also held senior leadership roles at IQVIA, where he led international teams and managed global evidence portfolios.
Throughout his career, Dr. Toussi has contributed to advancing scientific standards through organizations including ENCePP, ISPE, ISPOR, HTAi, and EU2P, authoring more than 50 publications and guidelines, and helping to develop innovative tools to improve evidence generation.
“Massoud’s arrival marks a significant step forward in strengthening UBC’s leadership in Real World Evidence. His deep expertise, global perspective, and proven track record in advancing high‑quality, fit‑for‑purpose evidence will meaningfully accelerate the impact we deliver for our clients and patients. We’re incredibly excited to welcome him to the organization and look forward to the innovation and rigor he will bring to our growing RWE portfolio.” said Aaron Berger, SVP, Evidence Development Solutions, UBC.
“I’m thrilled to be joining UBC at a pivotal moment for Real World Evidence,” said Massoud Toussi. “As healthcare decisions increasingly rely on high‑quality, fit‑for‑purpose real‑world data, UBC is uniquely positioned to shape the future of evidence generation. My joining also coincides with the integration of Evidinno which I welcome as a true added value to our portfolio. I’m excited to work with our teams and partners to advance innovative, scalable RWE solutions that deliver meaningful impact for patients, regulators, and life sciences organizations.”
About UBC
UBC is a leading provider of Evidence Generation Solutions – specializing in real-world evidence, late-stage research, and robust technology infrastructure to support all therapies from development through post-approval. UBC’s customized solutions leverage unrivaled expertise, real-world data, and the latest technologies to demonstrate long-term product value and support better patient outcomes.
For more information, please contact:
Natania Barron, Head of Marketing | Natania.barron@ubc.com
